Revaia is a Paris-based growth equity investment fund founded in 2018, focusing on partnering with mission-driven entrepreneurs to support European technology companies from growth stage to IPO or buyout, with a strong emphasis on…Read full bio
2 funds tracked, 21 portfolio companies (20 active · 1 realized). Verified weekly from public filings and deal announcements.
Revaia is a Paris-based growth equity investment fund with €600 million of assets under management, founded in 2018 and focusing on partnering with mission-driven entrepreneurs to support European technology companies from growth stage to IPO or buyout exit. The growth equity mandate distinguishes Revaia from early-stage VC peers, with the firm investing in profitable scaling tech companies with proven business models.
Revaia targets European technology companies at growth equity stage with €5 million-plus annual revenue and proven business models, deploying equity tickets typically ranging from €10 million to €40 million per transaction. Sector focus spans HealthTech, enterprise software, fintech and selectively other European tech verticals. The mission-driven entrepreneurship filter aligns Revaia's investment criteria with ESG-conscious limited partners seeking impact-aware growth equity exposure.
Recent realised exits include Hublo (healthcare, 2025), reflecting selective distribution activity across the European tech growth portfolio. The platform tracks 2 funds, 20 active portfolio companies and 1 realised exit across the growth equity programme. Detailed buyer names and multiple data available on Pro at €49/month.
Other private equity firms tracked on GP Intel.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in